OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Alnylam Pharmaceuticals/  US02043Q1076  /

IEX
6/17/2024  9:59:57 PM Chg. -2.97 Volume Bid- Ask- High Low
157.44USD -1.85% 48,198
Turnover: 7.68 mill.		 -Bid Size: - -Ask Size: - 165.69 156.54
GlobeNewswire 5/14 Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
GlobeNewswire 5/9 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 5/2 Codexis Reports First Quarter 2024 Financial Results
GlobeNewswire 5/2 PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
GlobeNewswire 5/2 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 4/23 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held M...
GlobeNewswire 4/11 Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
GlobeNewswire 4/1 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 3/15 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire 3/13 3Daughters Announces Three New Appointments to Board of Directors
GlobeNewswire 3/7 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmace...
GlobeNewswire 3/6 Zenas BioPharma Appoints Patricia Allen to its Board of Directors
GlobeNewswire 2/29 Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire 2/28 Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GlobeNewswire 2/28 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmace...
GlobeNewswire 2/20 Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
GlobeNewswire 2/2 Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
GlobeNewswire 1/17 Mary Beth DeLena Joins PepGen as General Counsel and Secretary
GlobeNewswire 12/13/2023 Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
GlobeNewswire 12/11/2023 Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeuti...
GlobeNewswire 11/28/2023 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...
GlobeNewswire 11/28/2023 Korro Bio Appoints Dr. Rachel Meyers to Board of Directors
GlobeNewswire 11/14/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmace...
GlobeNewswire 11/9/2023 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible S...
GlobeNewswire 11/8/2023 SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Alnylam Pharmaceuticals, Inc. of an I...